9994
M. Treus et al. / Tetrahedron 66 (2010) 9986e9995
extracts were dried, filtered and evaporated to dryness in vacuo, to
give a residue that was purified by column chromatography (2:3
AcOEt/hexane) to afford compound 19 (50 mg, 69% yield) as a white
Supplementary data
Supplementary data associated with this article can be found in
include MOL files and InChiKeys of the most important compounds
described in this article.
solid. Rf¼0.45 (60% AcOEt/hexane); IR (
n
, cmꢁ1, NaCl): 1677 (C]O),
1513 (NO2),1268 (NO2); 1H NMR (
d
, ppm, CDCl3): 3.33 (s, 3H, NCH3),
3.90 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 5.18 (d,1H, HC]CHH), 5.61 (d,
1H, HC]CHH), 6.45 (dd, 1H, Jcis]11 Hz, Jtrans¼17.3 Hz, HC]CH2),
6.86 (s, 1H, AreH), 7.13 (s, 1H, AreH), 7.48e7.55 (m, 1H, AreH),
7.72e7.77 (m, 2H, 2ꢂAreH), 8.33 (d, 1H, J¼7.9 Hz, AreH); 13C NMR
References and notes
(
d
, ppm, CDCl3): 33.2 (NCH3), 56.5 (2ꢂOCH3), 108.4 (CH), 110.9 (CH),
1. (a) Shamma, M. The Isoquinoline Alkaloids: Chemistry and Pharmacology, In.
Blomquist, A. T., Wasserman, H., Eds.; Academic Press: New York, London,
Verlag Chemie, Weinheim, 1972; (b) Shamma, M.; Moniot, J. L. Isoquinoline
Alkaloids Research 1972-1977, Plenum Press: New York, London, 1978; (c) Gui-
116.0 (CH2), 121.1 (C), 126.9 (C), 127.1 (CH), 127.5 (CH), 127.9 (CH),
129.1 (2ꢂC), 133.1 (CH), 134.8 (CH), 147.6 (C), 149.7 (C), 150.7 (C),
155.8 (C), 162.8 (C]O); MS (m/z, %): 321 (Mþꢁ44, 58), 58 (100).
Anal. Calcd for C20H19N2O5: C, 65.57; H, 4.95; N, 7.65. Found: C,
67.74; H, 5.22; N, 7.39.
ꢀ
naudeau, H.; Leboeuf, M.; Cave, A. J. Nat. Prod. 1990, 53, 235.
ꢀ
2. (a) Simanek, V. Benzophenanthridine Alkaloids In. The Alkaloids. Chemistry and
Pharmaology; Brossi, A., Ed.; Academic.: Orlando, 1985; Vol. 26; p 229; (b)
Bhakuni, D. S.; Jain, S. Protoberberine Alkaloids In. The Alkaloids. Chemistry and
Pharmacology; Brossi, A., Ed.; Academic.: Orlando, 1986; Vol. 28; p 169.
3. (a) Fang, S.-D.; Wang, L.-K.; Hetch, S. M. J. Org. Chem. 1993, 58, 5025; (b) Rashid,
M. A.; Gustafson, K. R.; Kashman, Y.; Cardellina, J. H., II; McMahon, J. B.; Boyd,
M. R. Nat. Prod. Lett. 1995, 6, 153; (c) Huang, F.-C.; Kutchan, T. M. Phytochemistry
2000, 53, 555; (d) Ishikawa, T. Med. Res. Rev. 2001, 21, 61; (e) Chang, Y.-C.; Hsieh,
P.-W.; Chang, F.-R.; Wu, R.-R.; Liaw, C.-C.; Lee, K.-H.; Wu, Y.-C. Planta Med. 2003,
69, 148.
4. (a) Cheng, C. C. Structural Aspects of Antineoplastic Agents-A New Approach In.
Progress in Medicinal Chemistry; Ellis, G. P., West, G. B., Eds.; Elsevier Science, B.
V. (Biomedical Division): Amsterdam, 1988; Vol. 25, pp 35e83; Vavreckova, C.;
Gawlik, I.; Muller, K. Planta Med. 1996, 62, 397; (b) Nakanishi, T.; Suzuki, M. J.
Nat. Prod. 1998, 61, 1263; (c) Fleury, F.; Sukhanova, A.; Ianoul, A.; Devy, J.; Ku-
delina, I.; Duval, O.; Alix, A. J. P.; Jardillier, J. C.; Nabiev, I. J. Biol. Chem. 2000, 275,
3501; (d) Gonzaga, W. A.; Weber, A. D.; Giacomelli, S. R.; Dalcol, I. I.; Hoelzel, S.
C. S.; Morel, A. F. Planta Med. 2003, 69, 371.
5. (a) Harvey, R. G. Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogene-
sis; Cambridge University: Cambridge, 1991; (b) Harvey, R. G. The Handbook of
Environmental Chemistry In. Part I: PAHs and Related Compounds; Hutzinger, O.,
Neilson, A., Eds.; Springer: Heidelberg, 1997; Vol. 3, pp 1e54 Chapter 1; (c) Wu
Harvey, R. G. Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenesis;
Wiley-VCH: New York, NY, 1997.
6. (a) Bernardo, P. H.; Chai, C. L. L.; Le Guen, M.; Smith, G. D.; Waring, P. Bioorg.
Med. Chem. Lett. 2007, 17, 82; (b) Marco-Contelles, J.; Molina, M. Curr. Org. Chem.
2003, 7, 1433; (c) Gould, S. J. Chem. Rev. 1997, 97, 2499; (d) Luo, Y.-L.; Chou, T.-C.;
Cheng, C. C. J. Heterocycl. Chem. 1996, 33, 113; (e) Mocellin, S. Microarray Tech-
nology and Cancer Gene Profiling; Springer: Heidelberg, 2007, Chapter 8, p 98.
7. (a) Bennasar, M.-L. l.; Roca, T.; Ferrando, F. J. Org. Chem. 2005, 70, 9077; (b)
Bernardo, P. H.; Chai, C. L. L.; Heath, G. A.; Mahon, P. J.; Smith, G. D.; Waring, P.;
Wilkes, B. A. J. Med. Chem. 2004, 47, 4958; (c) Mal, D.; Senapati, B. K.; Pahari, P.
Tetrahedron 2007, 63, 3768; (d) Ashcroft, W. R.; Dalton, L.; Beal, M. G.; Hum-
phrey, G. L.; Joule, J. A. J. Chem. Soc., Perkin Trans. 1 1983, 2409.
3.16. 3-(2-(2,2-Dimethoxyethyl)-4,5-dimethoxyphenyl)-5-
nitroisoquinolin-1(2H)-one (20)
A solution of thallium trinitratetrihydrate(68 mg, 0.154 mmol) in
dry MeOH (2 mL) was added to a solution of compound 19 (50 mg,
0.137 mmol) in dry MeOH (2 mL) and the reaction mixture was
stirred at rt for 5 min. It was then filtered and the MeOH of the filtrate
was evaporated off. The residue was taken up in CH2Cl2 and the
solution was washed with saturated aqueous NaHCO3 solution
(2ꢂ5 mL) and water (5 mL), dried and evaporated to dryness. The
resulting unstable derivative 20 was used as a crude for the next step
without further purification. Rf¼0.27 (60% AcOEt/hexane); 1H NMR
(
d
, ppm, CDCl3): 2.70 (dd,1H, J¼14, 4.5 Hz, ArCHH), 3.10 (dd,1H, J¼14,
6 Hz, ArCHH), 3.18 (s, 3H, CH3), 3.25 (s, 3H, CH3), 3.40 (s, 3H, CH3),
3.88 (s, 3H, CH3), 3.95 (s, 3H, CH3), 4.50 [dd, 1H, J¼6, 4.5 Hz, CH
(OMe)2], 6.79 (s, 1H, AreH), 6.96 (s, 1H, AreH), 7.53 (t, 1H, J¼6.6 Hz,
AreH), 7.74e7.77 (m, 2H, 2ꢂAreH), 8.35 (d, 1H, J¼8.1 Hz, AreH).
3.17. 6,7-Dimethoxy-2-(2-methylaminocarbonyl)isoquinolin-
1(2H)-one (21)
To a solution of recently obtained 20 in a 1:1 mixture of MeOH/
H2O (4 mL) p-toluensulfonic acid (52 mg, 0.273 mmol) was added
and the resulting solution was heated at 70 ꢀC for 2 days. The MeOH
was removed in vacuo and more water was added (2 mL). The
resulting suspension was extracted with CH2Cl2 (3ꢂ5 mL). The or-
ganic extracts were washed with 10% aqueous sodium hydroxide
solution (5 mL) and water (5 mL), dried and evaporated to dryness.
Column chromatography (CH2Cl2/MeOH 95:5) of the resulting solid
residue provided compound 21 (43 mg, 86% yield), as a yellow solid.
8. (a) Gribble, G. W. In The Alkaloids; Brossi, A., Ed.; Academic: New York, NY, 1990;
Vol. 39; p 239; (b) Suffness, M.; Cordell, G. A. In The Alkaloids; Brossi, A., Ed.;
Academic: New York, NY, 1985; Vol. 25, p 89; p 304; (c) Kansal, V. K.; Potier, P.
Tetrahedron 1986, 42, 2389; (d) Gribble, G. W.; Saulnier, M. G.; Obaza-Nutaitis,
J. A.; Ketcha, D. M. J. Org. Chem. 1992, 57, 5891; (e) Ishikura, M.; Yaginuma, T.;
Agata, I.; Miwa, Y.; Yanada, R.; Taga, T. Synlett 1997, 214; (f) Díaz, M. T.; Cobas,
ꢀ
€
A.; Guitian, E.; Castedo, L. Synlett 1998, 157; (g) Ergun, Y.; Patir, S.; Okay, G. J.
Heterocycl. Chem. 1998, 35, 1445; (h) Ishikura, M.; Hino, A.; Yaginuma, T.; Agata,
I.; Katagiri, N. Tetrahedron 2000, 56, 193; (i) Anderson, W. K.; Gopalsamy, A.;
Reddy, P. S. J. Med. Chem. 1994, 37, 1955.
Rf¼0.15 (80% AcOEt/hexane); IR (
n
, cmꢁ1, NaCl): 3313 (NH), 1651
9. Mackay, S. P.; Meth-Cohn, O.; Waich, R. D. Advances in Heterocyclic Chemistry;
Academic: New York, NY, 1997; Vol. 67,pp 345e389.
(C]O); 1H NMR (
d
, ppm, CDCl3): 2.71 (d, 3H, J¼5.2 Hz, NCH3), 4.02
10. For
a review covering benzo[c]phenanthridine synthesis until 1998, see:
(s, 3H, OCH3), 4.03 (s, 3H, OCH3), 6.53 (d, 1H, J¼7.3 Hz, AreH),
6.95e7.00 (m, 3H, NHþ2ꢂAreH), 7.25e7.28 (m, 1H, AreH),
7.51e7.56 (m, 2H, 2ꢂAreH), 7.67e7.71 (m, 1H, AreH), 7.80 (s, 1H,
Ishikawa, T.; Ishii, H. Heterocycles 1999, 50, 627 For more recent articles on this
topic, see: (a) Nakanishi, T.; Suzuki, M. Org. Lett. 1999, 1, 985; (b) Geen, G. R.;
Mann, I. S.; Mullane, M. V.; McKillop, A. Tetrahedron 1998, 54, 9875; (c)
Harayama, T.; Akamatsu, H.; Okamura, K.; Miyagoe, T.; Akiyama, T.; Abe, H.;
Takeuchi, Y. J. Chem. Soc., Perkin Trans. 1 2001, 523; (d) Treus, M.; Estevez, J. C.;
Castedo, L.; Estevez, R. J. Tetrahedron Lett. 2002, 43, 5323; (e) Le, T. N.; Gang,
S. G.; Cho, W.-J. J. Org. Chem. 2004, 69, 2768; (f) Harayama, T. Heterocycles
2005, 65, 697; (g) Styskala, J.; Cankar, P.; Soural, M.; Hlavac, J.; Hradil, P.;
Vicar, J.; Simanek, V. Heterocycles 2007, 73, 769; (h) Kohno, K.; Azuma, S.;
Choshi, T.; Nobuhiro, J.; Hibino, S. Tetrahedron Lett. 2009, 50, 590; (i)
Mandadapu, A. K.; Saifuddin, M.; Agarwal, P. K.; Kundu, B. Org. Biomol.
Chem. 2009, 7, 2796.
AreH); 13C NMR (
d
, ppm, CDCl3): 26.4 (CH3), 56.1 (2ꢂOCH3), 106.2
(2ꢂCH), 107.5 (CH), 119.5 (C), 128.2 (CH), 129.1 (2ꢂCH), 130.9
(2ꢂCH), 132.9 (C), 135.9 (C), 138.0 (C), 149.5 (C), 153.9 (C), 162.5 (C]
O), 167.7 (C]O); MS (m/z, %): 339 [(MþH)þ, 56], 308 (100). Anal.
Calcd for C19H18N2O4: C, 67.44; H, 5.36; N, 8.28. Found: C, 67.19; H,
5.53; N, 7.97.
11. See: Salas, C. O.; Reboredo, F. J.; Estevez, J. C.; Tapia, R.; Estevez, R. J. Synlett
2009, 3107 and references therein.
12. See: Mal, D.; Senapati, B. K.; Pahari, P. Tetrahedron 2007, 63, 3768 and references
therein.
Acknowledgements
We thank the Xunta de Galicia for financial support and for
providing a grant to M.T. The University of Santiago de Compostela
is also acknowledged for financial support for a visiting Professor-
ship for C.S. Additional thanks are given to FONDECYT (Research
Grants 11085027 and 1060592) for financial support.
13. (a) Du, C.; Chen, J.; Guo, Y.; Lu, K.; Ye, S.; Zheng, J.; Liu, Y.; Shuai, Z.; Yu, G. J. Org.
Chem. 2009, 74, 7322; (b) Brath, H.; Meskova, M.; Putala, M. Eur. J. Org. Chem.
2009, 3315; (c) Zhou, W.-J.; Wang, K.-H.; Wang, J.-X. J. Org. Chem. 2009, 74,
5599.
ꢀ
ꢀ
14. Treus, M.; Estevez, J. C.; Castedo, L.; Estevez, R. J. Tetrahedron Lett. 2000, 41,
6351.